Direct comparison of clinical decision limits for cardiac troponin T and I

Dorien M Kimenai1, Ronald M A Henry2, Carla J H van der Kallen2

  • 1Department of Clinical Chemistry, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.

Insights

High-sensitivity cardiac troponin (hs-cTn) thresholds for diagnosing heart attacks are similar between assays, despite current differences. Adjusting hs-cTnI limits for sex could prevent underdiagnosis, especially in women.

Area of Science:

  • Cardiology
  • Biomarker analysis
  • Clinical diagnostics

Background:

  • Current diagnostic thresholds for high-sensitivity cardiac troponin T (hs-cTnT) and troponin I (hs-cTnI) assays differ (14 ng/L and 26 ng/L, respectively).
  • These thresholds were established using separate reference populations, raising questions about their biological equivalence.
  • Understanding assay-specific reference limits is crucial for accurate acute myocardial infarction (AMI) diagnosis.

Purpose of the Study:

  • To directly compare sex- and age-specific 99th percentile upper reference limits for hs-cTnT and hs-cTnI within a single reference cohort.
  • To investigate whether current divergent hs-cTnT and hs-cTnI thresholds are due to intrinsic assay differences or cohort variations.
  • To inform potential adjustments in diagnostic criteria for AMI.

Main Methods:

  • A healthy reference population (n=1540) was selected from the Maastricht Study (n=3451), aged 40-75 years.
  • Exclusion criteria included diabetes, cardiovascular disease history, ECG abnormalities, elevated NT-proBNP, or reduced estimated glomerular filtration rate.
  • Non-parametric statistical methods were used to determine 99th percentile upper reference limits.

Main Results:

  • Overall 99th percentile upper reference limits were 15 ng/L for hs-cTnT and 13 ng/L for hs-cTnI.
  • Reference limits were higher in men than women for both assays (hs-cTnT: 16 vs 12 ng/L; hs-cTnI: 20 vs 11 ng/L).
  • Upper reference limits demonstrated an increasing trend with age for both hs-cTnT and hs-cTnI.

Conclusions:

  • Numerically similar thresholds for hs-cTnT and hs-cTnI assays were observed upon direct comparison.
  • The current hs-cTnI threshold of 26 ng/L may lead to underdiagnosis of AMI, particularly in women.
  • Sex-differentiated downward adjustment of the hs-cTnI threshold could align clinical decision limits and improve AMI detection.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
414
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
441
Comparing Experimental Results: Student's t-Test01:09

Comparing Experimental Results: Student's t-Test

The t-test is a statistical method used to compare the sample mean with a population mean or compare two means from two data sets. The test statistic is calculated from the standard deviation, mean, and number of measurements in the data set at a selected confidence interval and then compared to a table of critical values at this confidence level. If the test statistic is smaller than the critical value, the null hypothesis is accepted. In this case, we state that the difference between the...
6.4K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
791
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.5K